Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

Starting July 1, Medicare will cover three Ozempic-style weight-loss medications for $50 per month through a new temporary ...

Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.

Canadian patients with private coverage using an Ozempic® Savings Card - as well as those paying entirely out-of-pocket - will now get Ozempic® (semaglutide) at a price aligned with generic ...

Confused about Ozempic, Wegovy and Mounjaro? Here's what South Africans need to know about these prescription weight-loss ...

Novo Nordisk announced it will cut Wegovy and Ozempic list prices by up to 50% starting next year. (Dhiraj Singh/Bloomberg via Getty Images) Novo Nordisk on Tuesday announced plans to cut the list ...